RecruitingNCT03755726

A New Breath for Malignant Hypertension: Implementation of the HAMA Cohort

Sponsor

Centre Hospitalier de PAU

Enrollment

1,200 participants

Start Date

Sep 20, 2019

Study Type

OBSERVATIONAL

Conditions

Malignant Hypertension

Summary

This registry aims to provide the first prospective, multicentric database of patients with malignant hypertension. It will allow to assess modern epidemiology of the disease, diversity of current management and care pathway, to deepen our pathophysiological knowledges, to modernize the definition of this form of hypertension and its diagnostic criteria. The network that will emerge will finally lead to the opportunity of setting up therapeutic trials and establishing recommendations based on solid scientific evidence.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This trial is collecting detailed health data and building a registry of patients who develop malignant hypertension — an extremely high blood pressure emergency that causes damage to organs like the eyes, kidneys, and brain — to better understand this rare but serious condition. **You may be eligible if...** - You have been diagnosed with malignant hypertension: a blood pressure consistently above 180/110 with damage to the retina (back of the eye) - OR you have very high blood pressure (above 180/110) causing acute damage to three or more organ systems - You are 18 years or older - You are able to freely give your consent **You may NOT be eligible if...** - You are under 18 years old - You are unable to give free and informed consent or refuse to participate - You are on dialysis Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(37)

CH d'Annecy

Annecy, France

CH de la côte Basque

Bayonne, France

Avicenne APHP

Bobigny, France

CHU - Hôpital St André

Bordeaux, France

CH de Chalon sur Saone

Chalon-sur-Saône, France

CH Métropole

Chambéry, France

CHU de Clermont FERRAND

Clermont-Ferrand, France

Hôpital Henri Mondor

Créteil, France

CH de Dinard

Dinard, France

CHU Michallon

Grenoble, France

hôpital de Haguenau

Haguenau, France

Pôle Santé Sud

Le Mans, France

CH de Libourne

Libourne, France

CHRU de Lille

Lille, France

Clinique Vert Coteau

Marseille, France

Hopital de la conception

Marseille, France

CH Martigues

Martigues, France

CHU de Montellier

Montpellier, France

CHU - Hôpital Laennec

Nantes, France

Hôpital Saint Joseph

Paris, France

Hôpital Européen Georges Pompidou

Paris, France

APHP Bichat

Paris, France

Fondation Adolphe de Rothschild

Paris, France

Hôpital Tenon

Paris, France

CH de PAU

Pau, France

CHU de Pointe à Pitre

Pitres, France

CHU de Poitiers

Poitiers, France

CHU de Rennes

Rennes, France

CHU de ROUEN

Rouen, France

Clinique sainte Clotilde

Saint-Denis, France

CHU de St Etienne

Saint-Etienne, France

CH de St Nazaire

Saint-Nazaire, France

CHU de Strasbourg

Strasbourg, France

CHU de Toulouse Rangueil

Toulouse, France

CHU de Tours

Tours, France

CH de Valenciennes

Valenciennes, France

National Institute of Cardiology

Warsaw, Poland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03755726